Skip to main content

Table 2 Association of SII with clinicopathologic characteristics in patients with gastric cancer

From: Prognostic value of systemic immune-inflammation index in patients with gastric cancer

Characteristic

SII < 660 [cases (%)]

SII ≥ 660 [cases (%)]

Χ 2 value

P value

Total

283

161

  

Sex

  

0.051

0.821

 Men

178 (62.9)

103 (64.0)

  

 Women

105 (37.1)

58 (36.0)

  

Age (years)

  

9.250

0.002

 <60

174 (61.5)

75 (46.6)

  

 ≥60

109 (38.5)

86 (53.4)

  

Tumor location

  

5.667

0.059

 Upper stomach

82 (29.0)

58 (36.0)

  

 Middle stomach

83 (29.3)

54 (33.5)

  

 Lower stomach

118 (41.7)

49 (30.4)

  

Tumor size (cm)

  

20.867

<0.001

 <5

164 (58.0)

57 (35.4)

  

 ≥5

119 (42.0)

104 (64.6)

  

Pathologic type

  

4.642

0.326

 Adenocarcinoma

236 (83.4)

131 (81.4)

  

 Squamous carcinoma

12 (4.2)

13 (8.1)

  

 Adenosquamous carcinoma

3 (1.1)

0 (0.0)

  

 Ring cell carcinoma

26 (9.2)

13 (8.1)

  

 Undifferentiated carcinoma

6 (2.1)

4 (2.5)

  

Borrmann classification

  

10.079

0.039

 1

15 (5.3)

15 (9.3)

  

 2

74 (26.1)

24 (14.9)

  

 3

161 (56.9)

98 (60.9)

  

 4

28 (9.9)

22 (13.7)

  

 5

5 (1.8)

2 (1.2)

  

pT

  

23.504

<0.001

 1

46 (16.3)

7 (4.3)

  

 2

30 (10.6)

11 (6.8)

  

 3

115 (40.6)

60 (37.3)

  

 4

92 (32.5)

83 (51.6)

  

pN

  

12.925

0.005

 0

114 (40.3)

38 (23.6)

  

 1

109 (38.5)

76 (47.2)

  

 2

43 (15.2)

34 (21.1)

  

 3

17 (6.0)

13 (8.1)

  

pM

  

36.571

<0.001

 0

241 (85.2)

96 (59.6)

  

 1

42 (14.8)

65 (40.4)

  

TNM stage

  

40.848

<0.001

 I

62 (21.9)

15 (9.3)

  

 II

47 (16.6)

17 (10.6)

  

 III

132 (46.6)

64 (39.7)

  

 IV

42 (14.8)

65 (40.4)

  

CEA (μg/L)

  

4.778

0.029

 <5

261 (92.2)

138 (85.7)

  

 ≥5

22 (7.8)

23 (14.3)

  

NLR

  

52.974

<0.001

 <2.10

197 (69.6)

8 (5.0)

  

 ≥2.10

86 (30.4)

153 (95.0)

  

PLR

  

86.897

<0.001

 <120

137 (48.4)

7 (4.3)

  

 ≥120

146 (51.6)

154 (95.7)

  
  1. OS, overall survival; CI, confidence interval; CEA, carcinoembryonic antigen; NLR, neutrophil–lymphocyte ratio; PLR, platelet–lymphocyte ratio; SII, systemic immune-inflammation index